Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C20orf202 Inhibitors

C20orf202, short for "chromosome 20 open reading frame 202," is a protein encoded by a gene that resides on the 20th chromosome. This designation suggests that the protein is a product of a gene that was initially identified based on genomic sequencing projects, where it was recognized as an open reading frame-a sequence of DNA that is predicted to encode a protein-yet its biological function was not immediately clear.The functional characterization of C20orf202 is limited, reflecting the broader challenge in the post-genomic era of assigning roles to the numerous proteins that have been identified through these sequencing efforts. In the absence of detailed functional information, proteins like C20orf202 often become the subject of intense research to unravel their roles in cellular physiology and development.

Putative functions for C20orf202 might be hypothesized based on its amino acid sequence, domain structure, evolutionary conservation, expression pattern, and subcellular localization. For instance, if C20orf202 is conserved across species that share certain physiological traits, researchers might suspect that the protein plays a role in these conserved processes. Similarly, if C20orf202 contains domains that are known to participate in specific types of protein-protein interactions, it may be involved in corresponding signaling pathways or cellular structures.Altered expression or mutation of C20orf202 could potentially be associated with phenotypic consequences, contributing to disease pathology or affecting normal biological processes. Such associations can be identified through genetic studies linking variations in the C20orf202 gene to specific health conditions.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor, potentially affecting cell growth and proliferation pathways that could be relevant to C20orf202.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, involved in key signaling pathways related to cell survival and proliferation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), influencing various cellular processes.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 specifically inhibits MEK in the MAPK/ERK pathway, involved in cell differentiation and proliferation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK1/2 inhibitor, affecting the MAPK/ERK signaling pathway, potentially relevant to C20orf202.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, impacting stress-related cellular pathways and inflammatory responses.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, which is involved in apoptosis, inflammation, and cellular differentiation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor, affecting protein degradation and multiple signaling pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 inhibits the proteasome, leading to the accumulation of proteins and affecting cell cycle and apoptosis.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$75.00
256
(6)

Z-VAD-FMK is a pan-caspase inhibitor, potentially affecting apoptosis pathways related to C20orf202.